Search: onr:"swepub:oai:DiVA.org:liu-22460" >
Cytokine and chemok...
-
Nissinen, RDept of Mol Med National Publ Health, Helsingfors, Finland
(author)
Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis
- Article/chapterEnglish2004
Publisher, publication year, extent ...
-
2004-03-17
-
BMJ,2004
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:liu-22460
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-22460URI
-
https://doi.org/10.1136/ard.2003.008599DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Objectives: To analyse immunological changes during treatment with a monoclonal anti-tumour necrosis factor α (TNFα) antibody, infliximab, in patients with rheumatoid arthritis (RA). Methods: 25 patients with RA and 5 patients with other arthritides were studied during the first 6 weeks of treatment with infliximab. At the start of treatment and after 2 and 6 weeks, spontaneous expression of CCR3 and CCR5 on peripheral blood T cells and monocytes was studied by flow cytometry. The secretion and mRNA expression of interferon γ (IFNγ), interleukin (IL)4, IL5, and TNFα from phytohaemagglutinin (PHA) stimulated peripheral blood mononuclear cells was measured with an ELISA and RT-PCR. Plasma levels of C reactive protein, serum amyloid protein A, rheumatoid factor, and antibodies to filaggrin and citrullinated cyclic peptide were measured with an ELISA. Results: The number of CD4 T cells and CD14 monocytes expressing CCR3 (p = 0.013, p = 0.009, respectively) and CD8 T cells expressing CCR5 (p = 0.040) as well as PHA stimulated secretion of IL4 and IFNγ (p<0.05) increased during treatment in patients with RA. 15 (60%) patients with RA achieved clinical response (at least ACR20) during the first 2 weeks. The number of T cells expressing CCR3 and CCR5 was higher before treatment in non-responders than in responders (p<0.05). The number of T cells increased in responders. Conclusion: Increase in secretion of Th1 and Th2 cytokines together with induced expression of chemokine receptors on T cells and monocytes suggest restoration of peripheral cell mediated immunity and blockade of the accumulation of inflammatory cells in joints as response to treatment.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Leirisalo-Repo, MDept of Medicine, Div of Rheumatol Central Hospital, Helsingfors, Finland
(author)
-
Peltomaa, RDept of MEdicine, Div of Rheumatol Central Hospital, Helsingfors, Finland
(author)
-
Palosuo, TDept of Health and Functional Capacity National Public Health Inst, Helsingfors, Finland
(author)
-
Vaarala, Outi,1962-Östergötlands Läns Landsting,Linköpings universitet,Hälsouniversitetet,Pediatrik,Barn- och ungdomskliniken i Linköping(Swepub:liu)outva41
(author)
-
Dept of Mol Med National Publ Health, Helsingfors, FinlandDept of Medicine, Div of Rheumatol Central Hospital, Helsingfors, Finland
(creator_code:org_t)
Related titles
-
In:Annals of the Rheumatic Diseases: BMJ63:6, s. 681-6870003-49671468-2060
Internet link
Find in a library
To the university's database